Fig. 1From: The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant settingCONSORT diagram. CONSORT diagram indicating how patients were randomized for the I-SPY 2 TRIALBack to article page